Literature DB >> 17805532

Myocardial uptake of 99mTc-annexin-V and 111In-antimyosin-antibodies after ischemia-reperfusion in rats.

Laure Sarda-Mantel1, Florence Hervatin, Jean-Baptiste Michel, Liliane Louedec, Geneviève Martet, François Rouzet, Rachida Lebtahi, Pascal Merlet, Ban-An Khaw, Dominique Le Guludec.   

Abstract

OBJECTIVES: Phosphatidylserin exposure on cell surfaces occurs early during apoptosis and is detected in vivo by using (99m)Tc-annexin-V (ANX). Cardiomyocyte membrane disruption is detected in vivo by using (111)In-antimyosin-antibodies (AM). We aimed to determine if ANX and AM allow evaluation of the time-course of these two distinct cell death events after myocardial ischemia-reperfusion.
METHODS: Coronary tying (20 min) followed by reperfusion (IR) was performed in 31 rats. Twelve of the rats were injected with ANX, 11 with AM, and eight with both tracers. Myocardial uptake of tracers was studied 1-2 h, 4 h, or 24 h after IR by scintigraphy (ANX, n = 14) and autoradiography (all cases), and compared to histology and Apostain staining.
RESULTS: Scintigraphy was positive in all rats 2 h after IR and in three of five rats at 24 h. On autoradiography, ANX activity was intense in myocardial lesions as early as 1 h post-IR, whereas AM activity was mild at 2 h then increased at 4 h post-IR. ANX and AM uptakes evolved from mid-myocardium to endocardial and epicardial regions from 2 h to 24 h post-IR. Apostain staining was significant in myocardial lesions (p < 10(6) compared to six sham-operated rats). On histology, myocardial lesion was characterized by interstitial oedema, myocytes necrosis, and dramatic thinning at 24 h.
CONCLUSION: These data suggest that ANX and AM allow temporal and regional evaluations of PS exposure and membrane disruption, respectively, during myocytes death after 20-min myocardial ischemia followed by reperfusion. Also, (i) apoptosis starts very early in injured myocardium, (ii) myocyte necrosis occurs later (3-4 h post-reperfusion), and (iii) most dead cells are removed from mid-myocardium between 6 h and 24 h after reperfusion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805532     DOI: 10.1007/s00259-007-0559-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  38 in total

Review 1.  Intracellular ATP, a switch in the decision between apoptosis and necrosis.

Authors:  P Nicotera; M Leist; E Ferrando-May
Journal:  Toxicol Lett       Date:  1998-12-28       Impact factor: 4.372

2.  Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.

Authors:  K Ohtsuki; K Akashi; Y Aoka; F G Blankenberg; S Kopiwoda; J F Tait; H W Strauss
Journal:  Eur J Nucl Med       Date:  1999-10

3.  Invited commentary: P.S.* I love you: implications of phosphatidyl serine (PS) reversal in acute ischemic syndromes.

Authors:  Jagat Narula; H William Strauss
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

4.  Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart.

Authors:  E A Dumont; C P Reutelingsperger; J F Smits; M J Daemen; P A Doevendans; H J Wellens; L Hofstra
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

5.  Annexin-V imaging for noninvasive detection of cardiac allograft rejection.

Authors:  J Narula; E R Acio; N Narula; L E Samuels; B Fyfe; D Wood; J M Fitzpatrick; P N Raghunath; J E Tomaszewski; C Kelly; N Steinmetz; A Green; J F Tait; J Leppo; F G Blankenberg; D Jain; H W Strauss
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

Review 6.  Past, present, and future of annexin A5: from protein discovery to clinical applications.

Authors:  Hendrikus H Boersma; Bas L J H Kietselaer; Leo M L Stolk; Abdelkader Bennaghmouch; Leonard Hofstra; Jagat Narula; Guido A K Heidendal; Chris P M Reutelingsperger
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

7.  (99m)Tc-annexin V and (111)In-antimyosin antibody uptake in experimental myocardial infarction in rats.

Authors:  Laure Sarda-Mantel; Jean-Baptiste Michel; François Rouzet; Geneviève Martet; Liliane Louedec; Jean-Luc Vanderheyden; Florence Hervatin; Olivier Raguin; Jean-Marc Vrigneaud; Ban An Khaw; Dominique Le Guludec
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-11-10       Impact factor: 9.236

Review 8.  Apoptosis, oncosis, and necrosis. An overview of cell death.

Authors:  G Majno; I Joris
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

Review 9.  Non-invasive in vivo imaging of myocardial apoptosis and necrosis.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-14       Impact factor: 9.236

Review 10.  Morphological aspects of apoptosis in heart diseases.

Authors:  Genzou Takemura; Hisayoshi Fujiwara
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

View more
  9 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Molecular MRI of acute necrosis with a novel DNA-binding gadolinium chelate: kinetics of cell death and clearance in infarcted myocardium.

Authors:  Shuning Huang; Howard H Chen; Hushan Yuan; Guangping Dai; Daniel T Schuhle; Choukri Mekkaoui; Soeun Ngoy; Ronglih Liao; Peter Caravan; Lee Josephson; David E Sosnovik
Journal:  Circ Cardiovasc Imaging       Date:  2011-08-11       Impact factor: 7.792

3.  Synthesis and preliminary evaluation of radiolabeled bis(zinc(II)-dipicolylamine) coordination complexes as cell death imaging agents.

Authors:  Leonie Wyffels; Brian D Gray; Christy Barber; Stephen K Moore; James M Woolfenden; Koon Y Pak; Zhonglin Liu
Journal:  Bioorg Med Chem       Date:  2011-04-28       Impact factor: 3.641

4.  Molecular Imaging of Healing After Myocardial Infarction.

Authors:  Nivedita K Naresh; Tamar Ben-Mordechai; Jonathan Leor; Frederick H Epstein
Journal:  Curr Cardiovasc Imaging Rep       Date:  2011-02-01

5.  In-vivo monitoring of erythropoietin treatment after myocardial infarction in mice with [⁶⁸Ga]Annexin A5 and [¹⁸F]FDG PET.

Authors:  Andrei Todica; Mathias J Zacherl; Hao Wang; Guido Böning; Nathalie L Jansen; Carmen Wängler; Peter Bartenstein; Michael C Kreissl; Marcus Hacker; Stefan Brunner; Sebastian Lehner
Journal:  J Nucl Cardiol       Date:  2014-09-05       Impact factor: 5.952

6.  Imaging Myocardial Ischemia and Reperfusion Injury via Cy5.5-Annexin V.

Authors:  Rong Tian; DongFeng Pan
Journal:  Nucl Med Mol Imaging       Date:  2012-05-15

Review 7.  Imaging of apoptosis in the heart with nanoparticle technology.

Authors:  Howard H Chen; Lee Josephson; David E Sosnovik
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011 Jan-Feb

8.  Advances in radionuclide molecular imaging in myocardial biology.

Authors:  Alan R Morrison; Albert J Sinusas
Journal:  J Nucl Cardiol       Date:  2010 Jan-Feb       Impact factor: 5.952

9.  Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia.

Authors:  David E Sosnovik; Elisabeth Garanger; Elena Aikawa; Matthias Nahrendorf; Jose-Luiz Figuiredo; Guangping Dai; Fred Reynolds; Anthony Rosenzweig; Ralph Weissleder; Lee Josephson
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-29       Impact factor: 7.792

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.